http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009102364-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f4246e8fcebf17c365aced017a04c61
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-2208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75ff65ad9b96cfa84e1818f3e9713cef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38a19de5366b773ab9ad68a1f8c35d03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7f80185490d3863d4948b0e08b55d76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_812cceb87b1fa8632487c1e6d5a15e90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c99332e4db71ad47735128c27f3d125b
publicationDate 2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009102364-A
titleOfInvention Cocaine receptor binding ligand
abstract A novel compound is provided. The present invention relates to novel compounds that exhibit high affinity for cocaine receptors in the brain, particularly dopamine and serotonin transporter sites. The present invention can be used as an imaging agent or a pharmaceutical agent in the diagnosis and treatment of drug addiction, depression, anorexia and neurodegenerative diseases. [Selection figure] None
priorityDate 1996-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826

Total number of triples: 43.